Tuani, Renalyn C.
HRN: 11-89-84 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
AMPICILLIN 1GM (VIAL)
09/15/2022
09/21/2022
IV
2g
Q6
PROM
Waiting Final Action
11/21/2025
AMPICILLIN 1GM (VIAL)
11/21/2025
11/23/2025
IV
2gms
Q6hrs
Thinly MSAF
Checking Initial Appropriateness